The global fixed & mobile C-arms market size was valued at USD 1.68 billion in 2016 and is expected to grow at a CAGR of 3.4% over the forecast period. Mobile C-arms are expected to witness the fastest growth over the forecast period due to their tailored imaging solutions for a diverse range of clinical applications and greater flexibility in selection of navigation system. In addition, mobile C-arms have better maneuverability & precision and provide immediate hard copy of images, if need be, which expedites growth of the overall C-arms market.
U.S. fixed and mobile C-arms market revenue, by product, 2014 - 2025 (USD Million)
Rising geriatric population, which is highly susceptibility to various chronic conditions such as cardiovascular, orthopedic, and respiratory diseases, coupled with increasing patient awareness is expected to drive the market growth over the forecast period. In addition, increasing level of accuracy with 3D visualization has led to an increasing demand for these devices in the recent years, allowing healthcare experts to understand the intensity of a disease better.
These devices allow real-time viewing in image-guided surgeries. During the surgery of vascular abdominal aortic aneurysm, the main body of the stent graft is positioned right below the renal arteries; C-arms can assist in marking the anatomy as well as easy positioning of the device according the surgeon’s requirement, hence increasing the accuracy of C-arms in various surgeries.
In developing countries such as India, Mexico, and Brazil, governments are continuously investing huge amount of funds to improve patient-centered care. Expected growth of geriatric population, rise in prevalence of orthopedic injuries, and rapid growth in foreign investments is anticipated to boost the revenue generation in the developing nations of Asia Pacific, Latin America, and Middle East.
Mobile C-arm devices are good options for budget-conscious healthcare settings that have limited financial resources. Thus, demand for these devices is anticipated to grow at the fastest rate during the forecast period. In addition, mobile C-arms offer optimum angle for a high-quality images and allow easy movement & positioning (motorized axes), while keeping the patient comfortable. For instance, Ziehm Vision RFD Hybrid and RFD 3D are the first mobile C-arms that offer four motorized axes, helping the healthcare experts gain total control through a dual-joystick system. Full-size C-arms segment of mobile C-arms currently dominate the global market owing to their smaller size, lighter weight, and easy maneuverability as compared to mini C-arm devices.
Amongst full size and mini size mobile C-arms, the former captured the largest market share in 2016, as full-size C-arms have numerous medical applications and have higher prices. Moreover, adoption of full size devices is higher because of their longer existence and availability in the market.
Orthopedics & trauma segment dominated the market in 2016. The maneuverability of C-arm units for capturing accurate images from multiple positions is responsible for the largest share of the segment. In addition, these devices have wide applications in orthopedic surgeries due to their precision in operating rooms, which includes good image quality, operability, versatility, and efficiency. Products such as cios Alpha, cios Fusion, and cios Select from Siemens Healthineers have greatly contributed and set benchmarks in a number of orthopedic surgeries. Thus, rising number of orthopedic surgeries is anticipated to augment the market growth.
The market for pain management is expected to foresee the highest growth during the forecast period. Major factors such as higher resolution, faster workflow, and greater maneuverability for pain management are expected to boost growth of the market.
Global fixed and mobile C-arms market revenue, by product, 2016 (%)
North America dominated the fixed and mobile C-arms market with largest revenue share in 2016. The dominance of this region can be attributed to the well-established healthcare infrastructure, high adoption rate of advanced technology, and the presence of large target population. Furthermore, increasing incidence of chronic diseases is aggressively propelling the demand for C-arm equipment.
On the other hand, Asia Pacific is expected to witness the fastest growth during the forecast period. Presence of well-established hospitals and critical care centers as well as large target customer pool is anticipated to boost the growth. Furthermore, growing awareness of the population and booming medical tourism in the region are some additional factors expected to drive the Asia Pacific market.
Currently, the global C-arms space is consolidated in nature with only a few top companies capturing major share of the market. Some of the top companies operating in this industry are GE Healthcare; Philips Healthcare; Siemens AG; Hologic Corporation; Shimadzu Corporation; Toshiba Medical Systems; Ziehm Imaging; OrthoScan, Inc.; Hitachi Medical Systems; and Eurocolumbus s.r.l.
Numerous companies are focused on the introduction of technologically advanced X-ray intensifiers in order to gain a foothold in the fast-developing C-arms sector. In addition, partnerships, collaborations, and mergers with well-established C-arms manufacturing companies are the major strategies adopted by top players to increase the market share during the forecast period.
Report Attribute |
Details |
Market size value in 2020 |
USD 2.34 billion |
Revenue forecast in 2025 |
USD 1.5 billion |
Growth Rate |
CAGR of 7.9% from 2017 to 2025 |
Base year for estimation |
2016 |
Historical data |
2014 - 2016 |
Forecast period |
2017 - 2025 |
Quantitative units |
Revenue in USD million and CAGR from 2017 to 2025 |
Report coverage |
Revenue forecast, company share, competitive landscape, growth factors and trends |
Segments covered |
Product, application,, region |
Regional scope |
North America; Europe; Asia Pacific; Latin America; Middle East & Africa |
Country scope |
U.S.; Canada; UK; Germany; Japan; China; India; Brazil; Mexico; South Africa |
Key companies profiled |
A&D Medical (LifeSource); Opto Circuits (India) Limited; Exergen Corporation; Microlife Corporation; Omron Healthcare, Inc.; RADIANT INNOVATION INC.; Geratherm Medical AG; TERUMO CORPORATION; Citizen Systems; Welch Allyn |
Customization scope |
Free report customization (equivalent up to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope. |
Pricing and purchase options |
Avail customized purchase options to meet your exact research needs. Explore purchase options |
This report forecasts revenue growth at global, regional & country levels as well as provides an analysis on the latest trends and opportunities in each of the sub segments from 2014 to 2025. For the purpose of this study, Grand View Research has segmented the global fixed and mobile C-arms market on the basis of product, application, and region:
Product Outlook (Revenue, USD Million, 2014 - 2025)
Fixed C-arms
Mobile C-arms
Application Outlook (Revenue, USD Million, 2014 - 2025)
Orthopedics and Trauma
Neurosurgery
Cardiovascular
Pain Management
Gastroenterology
Others
Regional Outlook (Revenue, USD Million, 2014 - 2025)
North America
U.S.
Canada
Europe
UK
Germany
Asia Pacific
Japan
China
Latin America
Brazil
Mexico
MEA
South Africa
This report has a service guarantee. We stand by our report quality.
We are in compliance with GDPR & CCPR norms. All interactions are confidential.
Design an exclusive study to serve your research needs.
Get your queries resolved from an industry expert.
"The quality of research they have done for us has been excellent..."
With Covid-19 infections rising globally, the apprehension regarding a shortage of essential life-saving devices and other essential medical supplies in order to prevent the spread of this pandemic and provide optimum care to the infected also widens. In addition, till a pharmacological treatment is developed, ventilators act as a vital treatment preference for the COVID-19 patients, who may require critical care. Moreover, there is an urgent need for a rapid acceleration in the manufacturing process for a wide range of test-kits (antibody tests, self-administered, and others). The report will account for Covid19 as a key market contributor.